We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.71B
AUM Growth
+$182M
Cap. Flow
-$102M
Cap. Flow %
-1.32%
Top 10 Hldgs %
27.14%
Holding
420
New
12
Increased
175
Reduced
164
Closed
17

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$73.9M
2
MDT icon
Medtronic
MDT
+$52.6M
3
TFC icon
Truist Financial
TFC
+$30.9M
4
JNJ icon
Johnson & Johnson
JNJ
+$11.1M
5
HON icon
Honeywell
HON
+$10.3M

Top Sells

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$66.7M
2
SJM icon
J.M. Smucker
SJM
+$57.4M
3
KMB icon
Kimberly-Clark
KMB
+$35.4M
4
NVS icon
Novartis
NVS
+$19.8M
5
WEC icon
WEC Energy
WEC
+$5.61M

Sector Composition

Rank Sector Weight
1 Consumer Staples 16.9%
2 Healthcare 15.69%
3 Technology 15.19%
4 Financials 12.45%
5 Industrials 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIG icon
351
Vanguard Dividend Appreciation ETF
VIG
$114B
$313K ﹤0.01%
3,758
+963
+34% +$78.7K
SYF icon
352
Synchrony
SYF
$25.9B
$310K ﹤0.01%
12,259
-8,094
-40% -$236K
PRU icon
353
Prudential Financial
PRU
$41.7B
$308K ﹤0.01%
4,310
+1,075
+33% +$81.1K
YHOO
354
DELISTED
Yahoo Inc
YHOO
$300K ﹤0.01%
8,000
CAH icon
355
Cardinal Health
CAH
$55.9B
$293K ﹤0.01%
3,757
+557
+17% +$44.4K
NNN icon
356
NNN REIT
NNN
$8.94B
$291K ﹤0.01%
5,627
+127
+2% +$5.89K
C icon
357
Citigroup
C
$232B
$289K ﹤0.01%
6,813
+627
+10% +$27.7K
IWP icon
358
iShares Russell Mid-Cap Growth ETF
IWP
$20.5B
$287K ﹤0.01%
6,124
DE icon
359
Deere & Co
DE
$165B
$282K ﹤0.01%
3,475
+18
+0.5% +$1.48K
RAI
360
DELISTED
Reynolds American Inc
RAI
$282K ﹤0.01%
5,214
+15
+0.3% +$754
AET
361
DELISTED
Aetna Inc
AET
$280K ﹤0.01%
2,294
MCO icon
362
Moody's
MCO
$83.7B
$277K ﹤0.01%
2,960
TEVA icon
363
Teva Pharmaceuticals
TEVA
$40.6B
$272K ﹤0.01%
5,410
+5
+0.1% +$266
DOC icon
364
Healthpeak Properties
DOC
$15.1B
$270K ﹤0.01%
8,373
-946
-10% -$29.4K
ABB
365
DELISTED
ABB Ltd
ABB
$270K ﹤0.01%
13,640
TAP icon
366
Molson Coors Class B
TAP
$7.84B
$268K ﹤0.01%
2,650
-14
-0.5% -$1.38K
COP icon
367
ConocoPhillips
COP
$142B
$266K ﹤0.01%
6,101
-200
-3% -$8.82K
RYN icon
368
Rayonier
RYN
$6.6B
$250K ﹤0.01%
10,498
VBK icon
369
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24B
$248K ﹤0.01%
2,000
VSS icon
370
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
$247K ﹤0.01%
2,650
CSX icon
371
CSX Corp
CSX
$94.5B
$246K ﹤0.01%
28,275
+195
+0.7% +$1.7K
SMFG icon
372
Sumitomo Mitsui Financial
SMFG
$161B
$244K ﹤0.01%
42,680
+1,785
+4% +$10.9K
PID icon
373
Invesco International Dividend Achievers ETF
PID
$919M
$232K ﹤0.01%
16,473
-797
-5% -$11.3K
FBIN icon
374
Fortune Brands Innovations
FBIN
$6.27B
$224K ﹤0.01%
4,512
LCNB icon
375
LCNB Corp
LCNB
$280M
$224K ﹤0.01%
14,173

Similar funds

Bahl & Gaynor's Q2 2016 Portfolio in Review

As of Q2 2016, Bahl & Gaynor held 420 positions worth $7.71B, up 2.4% from $7.53B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q2 2016 filing shows 12 new, 175 increased, 164 reduced and 17 closed positions. Its largest new stake was Simpson Manufacturing: 23,694 shares worth $947K. The largest sale was Analog Devices, an estimated $66.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Bahl & Gaynor's largest Q2 2016 buy was Simpson Manufacturing: 23,694 shares worth $947K.
  • Bahl & Gaynor added most to Texas Instruments in Q2 2016, an estimated $73.9M increase.
  • Bahl & Gaynor's biggest Q2 2016 reduction was Analog Devices, cutting an estimated $66.7M.
  • Bahl & Gaynor fully exited Airgas Inc in Q2 2016, selling an estimated $3.17M.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $7.71B portfolio in Q2 2016.
  • Bahl & Gaynor opened 12 new positions and closed 17 in Q2 2016.
  • Bahl & Gaynor's portfolio value rose 2.4% quarter-over-quarter to $7.71B.

Based on Bahl & Gaynor's 13F filing for Q2 2016, filed 10 Aug 2016.